[Evaluation of the degree of malignancy of human gliomas by means of the determination of their GFA content (author's transl)].
The quantitative immunochemical determination of the GFA protein in a large number of brain tumors has shown a correlation between the malignancy of a glioma and its content in GFA. This dosage should help to establish the diagnosis, in addition to routine histological examinations. Its prognostic interest is currently debated.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001253:Astrocytes / Q000032:analysis; D001932:Brain Neoplasms / Q000032:analysis* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005904:Glial Fibrillary Acidic Protein; D005910:Glioma / Q000032:analysis* / Q000473:pathology; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000032:analysis*; D011379:Prognosis
D005904:Glial Fibrillary Acidic Protein; D009419:Nerve Tissue Proteins
Evaluation du degré de malignité des gliomes par la détermination de leur contenu en protéine gliofibrillaire (GFA).